Back to search

Article

Identification of pulmonary comorbid diseases network based repurposing effective drugs for COVID-19

2020-05-11

Abstract excerpt

The number of hospitalization of COVID-19 patients with one or more comorbid diseases is highly alarming. Despite the lack of large clinical data and incomplete understanding of virus pathology, identification of the COVID-19 associated diseases with clinical precision are highly limited. In this regard, our text mining of 6238 PubMed abstracts (as on 23 April 2020) successfully identified broad spectrum of COVID-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
131b14e1-9c15-53f9-ab07-843fc93c90cf
DOI
10.21203/rs.3.rs-28148/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of pulmonary comorbid diseases network based repurposing effective drugs for COVID-19DOI 10.21203/rs.3.rs-28148/v1
Lung Disease Network Reveals the Impact of Comorbidity on SARS-CoV-2 Infection and Opportunities of Drug RepurposingSemantic proximity
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19Semantic proximity
A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19Semantic proximity
Lung Disease Network Reveals the Impact of Comorbidity on SARS-CoV-2 infectionSemantic proximity
A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity
Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential TherapeuticsSemantic proximity
Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential TherapeuticsSemantic proximity
COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity
Impact of Comorbidity on Severity of Covid-19 Patients: A Network of Target Coding Genes PerspectiveSemantic proximity
Host - virus - drug interactions as determinants of COVID-19's phenotypes: A data-driven hypothesis.Semantic proximity
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity
Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation studySemantic proximity
Select a neighboring publication to make it the new centre.